During the past decade, Hospital de Montecelo conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital de Montecelo" #1 sponsor was "PETHEMA Foundation" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Ipsen" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Boehringer Ingelheim" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital de Montecelo" #1 collaborator was "Adknoma Health Research" with 1 trials as a collaborator, "Barcelona Supercomputing Center" with 1 trials as a collaborator, "Carlos III Health Institute" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Hospital de Montecelo" are "Crohn's Disease" (2 trials), "Hepatitis B, Chronic" (2 trials), "Acute Lymphoblastic Leukemia Ph Positive" (1 trials), "Acute Myeloblastic Leukaemia" (1 trials) and "Acute Promyelocytic Leukemia" (1 trials). Many other conditions were trialed in "Hospital de Montecelo" in a lesser frequency.

Most popular intervention types in "Hospital de Montecelo" are "Drug" (14 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "ARA-C" (2 trials), "Abrocitinib 200 mg" (2 trials), "Bortezomib" (2 trials) and "ATRA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital de Montecelo" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital de Montecelo". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 9 completed trials in Hospital de Montecelo, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital de Montecelo, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".